Endothelial effects of leptin: Implications in health and diseases

Current Diabetes Reports

Volumn 5, Issue 4, 2005, Pages 260-266

  Rahmouni, Kamal ^b   Haynes, William G ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; LEPTIN; LEPTIN RECEPTOR; N(G) NITROARGININE METHYL ESTER;

ANGIOGENESIS; ANTIHYPERTENSIVE ACTIVITY; ANTIOXIDANT ACTIVITY; ARTERIAL PRESSURE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CELL FUNCTION; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; HOMEOSTASIS; HORMONE ACTION; HUMAN; INFLAMMATION; MODULATION; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 24644456630     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-005-0020-5     Document Type: Review

References (49)

1. Friedman JM, Halaas JL: Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
2. Banks WA, Kastin AJ, Huang W, et al.: Leptin enters the brain by a saturable system independent of insulin. Peptides 1996, 17:305-311.
3. Farooqi IS, O'Rahilly S: Monogenic obesity in humans. Annu Rev Med 2005, 56:443-458.
4. Haynes WG, Morgan DA, Walsh SA, et al.: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997, 100:270-278.
5. Dunbar JC, Hu Y, Lu H: Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997, 46:2040-2043.
6. Sinha MK, Opentanova I, Ohannesian JP, et al.: Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996, 98:1277-1282.
7. Considine RV, Sinha MK, Heiman ML, et al.: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996, 334:292-295.
8. Rahmouni K, Correia ML, Haynes WG, Mark AL: Obesity-associated hypertension: new insights into mechanisms. Hypertension 2005, 45:9-14.
9. Tartaglia LA: The leptin receptor. J Biol Chem 1997, 272:6093-6096.
10. Chua SC Jr, Chung WK, Wu-Peng XS, et al.: Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science 1996, 271:994-996.
11. Phillips MS, Liu Q, Hammond HA, et al.: Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 1996, 13:18-19.
12. Sierra-Honigmann MR, Nath AK, Murakami C, et al.: Biological action of leptin as an angiogenic factor. Science 1998, 28:683-1686.
13. Bouloumie A, Drexler HC, Lafontan M, Busse R: Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 1998, 83:1059-1066.
14. Knudson JD, Dincer UD, Zhang C, et al.: Leptin receptors are expressed in coronary arteries and hyperleptinemia causes significant coronary endothelial dysfunction. Am J Physiol Heart Circ Physiol 2005, 289:H48-H56.
15. Golden PL, Maccagnan TJ, Pardridge WM: Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels. J Clin Invest1997, 99:14-18.
16. Niswender KD, Gallis B, Blevins JE, et al.: Immunocytochemical detection of phosphatidylinositol 3-kinase activation by insulin and leptin. J Histochem Cytochem 2003, 51:275-283.
17. Goetze S, Bungenstock A, Czupalla C, et al.: Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands. Hypertension 2002, 40:748-754.
18. Vecchione C, Maffei A, Colella S, et al.: Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes 2002, 51:168-173.
19. Bouloumie A, Marumo T, Lafontan M, Busse R: Leptin induces oxidative stress in human endothelial cells. FASEB J 1999, 13:1231-1238.
20. Yamagishi SI, Edelstein D, Du XL, et al.: Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem 2001, 276:25096-25100.
21. Jin X, Fukuda N, Su J, et al.: Effects of leptin on endothelial function with OB-Rb gene transfer in Zucker fatty rats. Atherosclerosis 2003, 169:225-233.
22. Rupnick MA, Panigrahy D, Zhang CY, et al.: Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A 2002, 99:10730-10735.
23. Cao R, Brakenhielm E, Wahlestedt C, et al.: Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF. Proc Natl Acad Sci U S A 2001, 98:6390-6395.
24. Suganami E, Takagi H, Ohashi H, et al.: Leptin stimulates ischemia-induced retinal neovascularization: possible role of vascular endothelial growth factor expressed in retinal endothelial cells. Diabetes 2004, 53:2443-2448.
25. Uckaya G, Ozata M, Sonmez A, et al.: Is leptin associated with hypertensive retinopathy? J Clin Endocrinol Metab 2000, 85:683-687.
26. Park HY Kwon HM, Lim HJ, et al.: Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 2001, 33:95-102.
27. Newby AC: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 2005, 85:1-31.
28. Schafer K, Halle M, Goeschen C, et al.: Leptin promotes vascular remodeling and neointimal growth in mice. Arterioscler Thromb Vasc Biol 2004, 24:112-117.
29. Frank S, Stallmeyer B, Kampfer H, et al.: Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 2000, 106:501-509.
30. Ring BD, Scully S, Davis CR, et al.: Systemically and topically administered leptin both accelerate wound healing in diabetic ob/ob mice. Endocrinology 2000, 141:446-449.
31. Wolf G, Hamann A, Han DC, et al.: Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999, 56:860-872.
32. Beltowski J, Wojcicka G, Jamroz A: Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Atherosclerosis 2003, 170:21-29.
33. Nakazono K, Watanabe N, Matsuno K, et al.: Does superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A 1991, 88:10045-10048.
34. Beltowski J, Wojcicka G, Marciniak A, Jamroz A: Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension. Life Sci 2004, 74:2987-3000.
35. Contreras F, Rivera M, Vasquez J, et al.: Endothelial dysfunction in arterial hypertension. J Hum Hypertens 2000, 14:S20-S25.
36. Lembo G, Vecchione C, Fratta L, et al.: Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes 2000, 49:293-297.
37. Kimura K, Tsuda K, Baba A, et al.: Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun 2000, 273:745-749.
38. Winters B, Mo Z, Brooks-Asplund E: Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice. J Appl Physiol 2000, 89:2382-2390.
39. Pannirselvam M, Verma S, Anderson TJ, Triggle CR: Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db -/-) mice: role of decreased tetrahydrobiopterin bioavailability. Br J Pharmacol 2002, 136: 255-263.
40. Nakagawa K, Higashi Y, Sasaki S, et al.: Leptin causes vasodilation in humans. Hypertens Res 2002, 25:161-165.
41. Matsuda K, Teragawa. H, Fukuda Y, et al.: Leptin causes nitric-oxide independent coronary artery vasodilation in humans. Hypertens Res 2003, 26:147-152.
42. Fruhbeck G: Pivotal role of nitric oxide in the control of blood pressure after leptin administration. Diabetes 1999, 48:903-908.
43. Gardiner SM, Kemp PA, Mardi JE, Bennett T: Regional haemodynamic effects of recombinant murine or human leptin in conscious rats. Br J Pharmacol 1999, 130:805-810.
44. Mitchell JL, Morgan DA, Correia ML, et al.: Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation? Hypertension 2001, 38:1081-1086.
45. Jalali A, Morgan DA, Sivitz WI, et al.: Does leptin cause functional peripheral sympatholysis? Am J Hypertens 2001, 14:615-618.
46. Kuo JJ, Jones OB, Hall JE: Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin. Hypertension 2001, 37:670-676.
47. Zanetti M, Barazzoni R, Vadori M, et al.: Lack of direct effect of moderate hyperleptinemia to improve endothelial function in lean rat aorta: role of calorie restriction. Atherosclerosis 2004, 175:253-259.
48. Aizawa-Abe M, Ogawa Y, Masuzaki H, et al.: Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000, 105:1243-1252.
49. Mark AL, Shaffer RA, Correia ML, et al.: Contrasting blood pressure effects of obesity in leptin-deficient ob/ob mice and agouti yellow obese mice. J Hypertens 1999, 17:1949-1953.